Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure
Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy con...
Gespeichert in:
Veröffentlicht in: | Muscle & nerve 2001-01, Vol.24 (1), p.69-76 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 76 |
---|---|
container_issue | 1 |
container_start_page | 69 |
container_title | Muscle & nerve |
container_volume | 24 |
creator | Green, H.J. Duscha, B.D. Sullivan, M.J. Keteyian, S.J. Kraus, W.E. |
description | Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P > 0.05). Similarly, no differences (P > 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P < 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 69–76, 2001 |
doi_str_mv | 10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70573048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70573048</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</originalsourceid><addsrcrecordid>eNqNkF1rFDEUQAdR7Lb6F2RAEKXMmq-ZZFYRyqq1uN0Ba7d9u6Txhh07X01mqP33ZpxlffHBp9yEw8nlRFFKyZwSwt5SkstEpLl6zQihhL5hYkHfZ_licXL2MTm_vFAf-JzMl8U7lhSPotmefxzNCBUqyXh-fRAdev-TBIHK5NPogFKakjxTs-hq3bpaV7G_xQr7MNSDNxXGa32cfD2Ou6HuYtM2Bpve6b5sm7hs4i5M4cHH92W_jc3WtU1p4i1q18dWl9Xg8Fn0xOrK4_PdeRRdfv70ffklWRWnZ8uTVWLEuFxOuMilYiJnaFAbqtNUy_QGpVGGKioypbhiVjGJFLmSCq3lSihtZWot8qPo1eTtXHs3oO-hLr3BqtINtoMHSVLJiVABPJ9A41rvHVroXFlr9wCUwFgaxnIwloOpNDABFLIcIJSGsTRwILAsgEERfC92Hw83Nf74a9ulDcDLHaC90ZV1ujGl33N5ljHBA7WeqPuywof_3-kfK_25B2EyCUvf46-9ULtbyCSXKVytT2F1wb5tNptryPhv5IWxFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70573048</pqid></control><display><type>article</type><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</creator><creatorcontrib>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</creatorcontrib><description>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P > 0.05). Similarly, no differences (P > 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P < 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 69–76, 2001</description><identifier>ISSN: 0148-639X</identifier><identifier>EISSN: 1097-4598</identifier><identifier>DOI: 10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O</identifier><identifier>PMID: 11150968</identifier><identifier>CODEN: MUNEDE</identifier><language>eng</language><publisher>New York: John Wiley & Sons, Inc</publisher><subject>Binding, Competitive - drug effects ; Biological and medical sciences ; Cardiology. Vascular system ; Chronic Disease ; chronic heart failure ; Citrate (si)-Synthase - metabolism ; Digoxin - administration & dosage ; Exercise - physiology ; exercise intolerance ; Exercise Tolerance - drug effects ; Exercise Tolerance - physiology ; Female ; Heart ; Heart Failure - metabolism ; Heart failure, cardiogenic pulmonary edema, cardiac enlargement ; Humans ; Male ; Medical sciences ; Middle Aged ; Muscle, Skeletal - chemistry ; Muscle, Skeletal - metabolism ; Oxidation-Reduction - drug effects ; peak aerobic power ; Sex Factors ; skeletal muscle ; sodium-potassium pump ; Sodium-Potassium-Exchanging ATPase - analysis ; Sodium-Potassium-Exchanging ATPase - metabolism ; Stroke Volume ; training</subject><ispartof>Muscle & nerve, 2001-01, Vol.24 (1), p.69-76</ispartof><rights>Copyright © 2001 John Wiley & Sons, Inc.</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2001 John Wiley & Sons, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F1097-4598%28200101%2924%3A1%3C69%3A%3AAID-MUS8%3E3.0.CO%3B2-O$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F1097-4598%28200101%2924%3A1%3C69%3A%3AAID-MUS8%3E3.0.CO%3B2-O$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,4024,27923,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=966243$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11150968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Green, H.J.</creatorcontrib><creatorcontrib>Duscha, B.D.</creatorcontrib><creatorcontrib>Sullivan, M.J.</creatorcontrib><creatorcontrib>Keteyian, S.J.</creatorcontrib><creatorcontrib>Kraus, W.E.</creatorcontrib><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><title>Muscle & nerve</title><addtitle>Muscle Nerve</addtitle><description>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P > 0.05). Similarly, no differences (P > 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P < 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 69–76, 2001</description><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cardiology. Vascular system</subject><subject>Chronic Disease</subject><subject>chronic heart failure</subject><subject>Citrate (si)-Synthase - metabolism</subject><subject>Digoxin - administration & dosage</subject><subject>Exercise - physiology</subject><subject>exercise intolerance</subject><subject>Exercise Tolerance - drug effects</subject><subject>Exercise Tolerance - physiology</subject><subject>Female</subject><subject>Heart</subject><subject>Heart Failure - metabolism</subject><subject>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muscle, Skeletal - chemistry</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Oxidation-Reduction - drug effects</subject><subject>peak aerobic power</subject><subject>Sex Factors</subject><subject>skeletal muscle</subject><subject>sodium-potassium pump</subject><subject>Sodium-Potassium-Exchanging ATPase - analysis</subject><subject>Sodium-Potassium-Exchanging ATPase - metabolism</subject><subject>Stroke Volume</subject><subject>training</subject><issn>0148-639X</issn><issn>1097-4598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1rFDEUQAdR7Lb6F2RAEKXMmq-ZZFYRyqq1uN0Ba7d9u6Txhh07X01mqP33ZpxlffHBp9yEw8nlRFFKyZwSwt5SkstEpLl6zQihhL5hYkHfZ_licXL2MTm_vFAf-JzMl8U7lhSPotmefxzNCBUqyXh-fRAdev-TBIHK5NPogFKakjxTs-hq3bpaV7G_xQr7MNSDNxXGa32cfD2Ou6HuYtM2Bpve6b5sm7hs4i5M4cHH92W_jc3WtU1p4i1q18dWl9Xg8Fn0xOrK4_PdeRRdfv70ffklWRWnZ8uTVWLEuFxOuMilYiJnaFAbqtNUy_QGpVGGKioypbhiVjGJFLmSCq3lSihtZWot8qPo1eTtXHs3oO-hLr3BqtINtoMHSVLJiVABPJ9A41rvHVroXFlr9wCUwFgaxnIwloOpNDABFLIcIJSGsTRwILAsgEERfC92Hw83Nf74a9ulDcDLHaC90ZV1ujGl33N5ljHBA7WeqPuywof_3-kfK_25B2EyCUvf46-9ULtbyCSXKVytT2F1wb5tNptryPhv5IWxFA</recordid><startdate>200101</startdate><enddate>200101</enddate><creator>Green, H.J.</creator><creator>Duscha, B.D.</creator><creator>Sullivan, M.J.</creator><creator>Keteyian, S.J.</creator><creator>Kraus, W.E.</creator><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200101</creationdate><title>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</title><author>Green, H.J. ; Duscha, B.D. ; Sullivan, M.J. ; Keteyian, S.J. ; Kraus, W.E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4148-90349782492eceac1a55a75be7c8c1814688382f827e1e3878eff3848af75ffe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cardiology. Vascular system</topic><topic>Chronic Disease</topic><topic>chronic heart failure</topic><topic>Citrate (si)-Synthase - metabolism</topic><topic>Digoxin - administration & dosage</topic><topic>Exercise - physiology</topic><topic>exercise intolerance</topic><topic>Exercise Tolerance - drug effects</topic><topic>Exercise Tolerance - physiology</topic><topic>Female</topic><topic>Heart</topic><topic>Heart Failure - metabolism</topic><topic>Heart failure, cardiogenic pulmonary edema, cardiac enlargement</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muscle, Skeletal - chemistry</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Oxidation-Reduction - drug effects</topic><topic>peak aerobic power</topic><topic>Sex Factors</topic><topic>skeletal muscle</topic><topic>sodium-potassium pump</topic><topic>Sodium-Potassium-Exchanging ATPase - analysis</topic><topic>Sodium-Potassium-Exchanging ATPase - metabolism</topic><topic>Stroke Volume</topic><topic>training</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Green, H.J.</creatorcontrib><creatorcontrib>Duscha, B.D.</creatorcontrib><creatorcontrib>Sullivan, M.J.</creatorcontrib><creatorcontrib>Keteyian, S.J.</creatorcontrib><creatorcontrib>Kraus, W.E.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Muscle & nerve</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Green, H.J.</au><au>Duscha, B.D.</au><au>Sullivan, M.J.</au><au>Keteyian, S.J.</au><au>Kraus, W.E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure</atitle><jtitle>Muscle & nerve</jtitle><addtitle>Muscle Nerve</addtitle><date>2001-01</date><risdate>2001</risdate><volume>24</volume><issue>1</issue><spage>69</spage><epage>76</epage><pages>69-76</pages><issn>0148-639X</issn><eissn>1097-4598</eissn><coden>MUNEDE</coden><abstract>Intrinsic changes in skeletal muscle are being increasingly suspected as part of the underlying cause of exercise intolerance in patients with chronic heart failure (CHF). The objective of the present study was to determine whether differences existed between CHF patients and age‐matched healthy controls in the concentration of skeletal muscle Na+‐K+–ATPase (adenosine triphosphatase), a cation pump that functions to restore Na+‐K+ gradients and protect membrane excitability. Moreover, given the potency for physical activity in altering long‐term regulation of the pump, an additional objective was to examine the role of activity level in pump expression in CHF patients. Na+‐K+–ATPase concentration (pmol/g wet wt) determined in the vastus lateralis muscle of 27 CHF males (ejection fraction, 23 ± 1.6%), using the vanadate facilitated [3H] ouabain binding technique, was not different (264 ± 10) from 10 sedentary controls (268 ± 19,P > 0.05). Similarly, no differences (P > 0.05) could be found between female patients (228 ± 16, n = 7) and controls (243 ± 13, n = 9). Differences between untrained control (294 ± 20, n = 7), chronically active (251 ± 20, n = 9), and trained (252 ± 16, n = 6) CHF groups in Na+‐K+ pump expression were also insignificant. This study indicates that long‐term regulation of Na+‐K+–ATPase concentration is not altered in moderate CHF patients, regardless of the history of regular activity. However, the positive correlations (P < 0.05) that were observed between peak aerobic power (V̇O2 peak) and Na+‐K+–ATPase (r = 0.422) and V̇O2 peak and maximal citrate synthase activity (r = 0.404) suggests a role for the skeletal muscle in explaining exercise intolerance in CHF patients. © 2001 John Wiley & Sons, Inc. Muscle Nerve 24: 69–76, 2001</abstract><cop>New York</cop><pub>John Wiley & Sons, Inc</pub><pmid>11150968</pmid><doi>10.1002/1097-4598(200101)24:1<69::AID-MUS8>3.0.CO;2-O</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0148-639X |
ispartof | Muscle & nerve, 2001-01, Vol.24 (1), p.69-76 |
issn | 0148-639X 1097-4598 |
language | eng |
recordid | cdi_proquest_miscellaneous_70573048 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Binding, Competitive - drug effects Biological and medical sciences Cardiology. Vascular system Chronic Disease chronic heart failure Citrate (si)-Synthase - metabolism Digoxin - administration & dosage Exercise - physiology exercise intolerance Exercise Tolerance - drug effects Exercise Tolerance - physiology Female Heart Heart Failure - metabolism Heart failure, cardiogenic pulmonary edema, cardiac enlargement Humans Male Medical sciences Middle Aged Muscle, Skeletal - chemistry Muscle, Skeletal - metabolism Oxidation-Reduction - drug effects peak aerobic power Sex Factors skeletal muscle sodium-potassium pump Sodium-Potassium-Exchanging ATPase - analysis Sodium-Potassium-Exchanging ATPase - metabolism Stroke Volume training |
title | Normal skeletal muscle Na+-K+ pump concentration in patients with chronic heart failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A10%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Normal%20skeletal%20muscle%20Na+-K+%20pump%20concentration%20in%20patients%20with%20chronic%20heart%20failure&rft.jtitle=Muscle%20&%20nerve&rft.au=Green,%20H.J.&rft.date=2001-01&rft.volume=24&rft.issue=1&rft.spage=69&rft.epage=76&rft.pages=69-76&rft.issn=0148-639X&rft.eissn=1097-4598&rft.coden=MUNEDE&rft_id=info:doi/10.1002/1097-4598(200101)24:1%3C69::AID-MUS8%3E3.0.CO;2-O&rft_dat=%3Cproquest_cross%3E70573048%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70573048&rft_id=info:pmid/11150968&rfr_iscdi=true |